These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8632897)

  • 1. 17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation.
    Bonapace IM; Addeo R; Altucci L; Cicatiello L; Bifulco M; Laezza C; Salzano S; Sica V; Bresciani F; Weisz A
    Oncogene; 1996 Feb; 12(4):753-63. PubMed ID: 8632897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.
    Altucci L; Addeo R; Cicatiello L; Dauvois S; Parker MG; Truss M; Beato M; Sica V; Bresciani F; Weisz A
    Oncogene; 1996 Jun; 12(11):2315-24. PubMed ID: 8649771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors.
    Addeo R; Altucci L; Battista T; Bonapace IM; Cancemi M; Cicatiello L; Germano D; Pacilio C; Salzano S; Bresciani F; Weisz A
    Biochem Biophys Res Commun; 1996 Mar; 220(3):864-70. PubMed ID: 8607857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
    Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
    Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
    Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
    Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
    Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
    Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth.
    Di Domenico M; Castoria G; Bilancio A; Migliaccio A; Auricchio F
    Cancer Res; 1996 Oct; 56(19):4516-21. PubMed ID: 8813150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
    J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
    Migliaccio A; Di Domenico M; Castoria G; de Falco A; Bontempo P; Nola E; Auricchio F
    EMBO J; 1996 Mar; 15(6):1292-300. PubMed ID: 8635462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of JNK/SAPK pathway is not directly inhibitory for cell cycle progression in NIH3T3 cells.
    Shu J; Hitomi M; Stacey D
    Oncogene; 1996 Dec; 13(11):2421-30. PubMed ID: 8957084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity.
    Wang LH; Yang XY; Zhang X; Mihalic K; Xiao W; Farrar WL
    Cancer Res; 2003 May; 63(9):2046-51. PubMed ID: 12727818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP; Buckley DJ; Buckley AR
    Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.
    Dees C; Askari M; Foster JS; Ahamed S; Wimalasena J
    Mol Carcinog; 1997 Feb; 18(2):107-14. PubMed ID: 9049186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
    Duncan RE; Lau D; El-Sohemy A; Archer MC
    Biochem Pharmacol; 2004 Nov; 68(9):1739-47. PubMed ID: 15450939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
    Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
    J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
    Fouty BW; Rodman DM
    Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells.
    Muscella A; Greco S; Elia MG; Storelli C; Marsigliante S
    J Cell Physiol; 2003 Oct; 197(1):61-8. PubMed ID: 12942541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells.
    Fenig E; Wieder R; Paglin S; Wang H; Persaud R; Haimovitz-Friedman A; Fuks Z; Yahalom J
    Clin Cancer Res; 1997 Jan; 3(1):135-42. PubMed ID: 9815549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.